Results 141 to 150 of about 56,556 (236)

Assessment of the feed additive consisting of lasalocid A sodium (Avatec® 150G) for turkeys, pheasants, guinea fowl, quails and partridges except laying birds thereof for the renewal of its authorisation (Zoetis Belgium SA)

EFSA Journal, Volume 24, Issue 8, August 2026.
Abstract Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of lasalocid A sodium (Avatec® 150G) as a coccidiostat for turkeys, pheasants, guinea fowl, quails and partridges. The additive currently on the market complies with the existing conditions of authorisation.
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Roberto Edoardo Villa, Giovanna Azimonti, Eleftherios Bonos, Henrik Christensen, Mojca Durjava, Birgit Dusemund, Ronette Gehring, Boet Glandorf, Maryline Kouba, Marta López‐Alonso, Francesca Marcon, Giovanna Martelli, Carlo Nebbia, Alena Pechová, Miguel Prieto‐Maradona, Katerina Theodoridou, Pier Sandro Cocconcelli, Jürgen Gropp, Guido Rychen, Ivana Teodorivic, Jaume Galobart, Fabiola Pizzo, Maria Vittoria Vettori, Orsolya Holczknecht, Elisa Petenatti, Alberto Navarro‐Villa   +26 more
wiley   +1 more source

Diversity of antibiotic resistance genes increases in urbanized lakes: A multi-tool screening. [PDF]

iScience
De Yebra P, Zoccarato L, Galindo JA, Numberger D, Abdulkadir N, Grossart HP, Greenwood AD.   +6 more
europepmc   +1 more source

Reusing health records from farm animal practices at scale: A potential complementary method of surveillance

Veterinary Record, Volume 199, Issue 2, Page e73-e81, 18/25 July 2026.
Abstract Background Disease in primary care frequently represents a surveillance blind spot, particularly for diseases affecting farm animals. Methods Electronic health records (EHRs) were collected from four farm animal veterinary practices in Wales (February 2024‒January 2025) as part of a pilot study.
Beverley Hopkins, Peers Davies, Peter‐John Noble, Anna Bunford‐Davies, April Lawson, Gina Pinchbeck, Ifan Lloyd, Robert Smith, Alan D. Radford   +8 more
wiley   +1 more source

A systematic literature review and (network) meta-analysis of the effectiveness of ceftolozane/tazobactam versus aminoglycosides/polymyxins and ceftazidime/avibactam for treating adult patients with multidrug-resistant <i>Pseudomonas aeruginosa</i> infections. [PDF]

Antimicrob Agents Chemother
Collings H, Stone M, Chrysostomou M, Hirst A, Waldenberg TE, Yucel E, Iodise T.   +6 more
europepmc   +1 more source

Synergistic Effects of Amikacin With Imipenem and Ciprofloxacin Against Multidrug-Resistance Uropathogenic <i>Escherichia coli</i>. [PDF]

Can J Infect Dis Med Microbiol
Moharerpour SS, Ahmadi Parviji F, Javadi K, Halaji M.   +3 more
europepmc   +1 more source

One-Day Aminoglycosides versus Three-Day Ceftazidime for Perioperative Prophylaxis and Postoperative Sepsis Risk in Patients with Urinary Calculi: A Propensity Score-Matched Retrospective Cohort Analysis. [PDF]

Drug Des Devel Ther
Sun S, Guo J, Zhang Z, Guo D, Li J, Cai X.   +5 more
europepmc   +1 more source

Glycan-binding properties of SARS-CoV-2 spike proteins: interactions with aminoglycoside antibiotics. [PDF]

Sci Rep
Hatakeyama D, Shoji M, Miki Y, Ueki S, Yamaguchi K, Nakashima K, Tanaka Y, Yokogawa M, Osawa M, Kasai Y, Imagawa H, Hashimoto R, Takayama K, Kuzuhara T.   +13 more
europepmc   +1 more source

Identification of small molecules that enhance aminoglycoside-mediated suppression of <i>CFTR</i> and <i>NF1</i> nonsense mutations. [PDF]

Mol Ther Oncol
Sammons J, Chen J, Thrasher K, Fu L, Du M, Wen H, Bostwick JR, Vinson P, Moukha-Chafiq O, Augelli-Szafran C, Keeling KM, Wallis D, Kesterson RA, Rowe SM, Bedwell DM.   +14 more
europepmc   +1 more source

Multidrug-Resistant <i>Escherichia coli</i> Causing Respiratory and Systemic Infection in a Guinea Pig (<i>Cavia porcellus</i>) in Romania: A Case Report. [PDF]

Vet Sci
Gligor A, Iorgoni V, Nistor P, Popa SA, Popa I, Iancu I, Nichita I, Imre K, Tîrziu E, Herman V.   +9 more
europepmc   +1 more source

Changes in Susceptibility Profiles of <i>Acinetobacter baumannii</i> Clinical Isolates in a Multi-Profile Hospital in Years 2020-2024 in Lodz, Poland. [PDF]

J Clin Med
Bekier A, Bielec F, Grędysa M, Miaśkiewicz E, Nowak M, Pastuszak-Lewandoska D, Brauncajs M.   +6 more
europepmc   +1 more source